Insider Trading activities of Aeglea Biotherapeutics, Inc. (AGLE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aeglea Biotherapeutics, Inc. (AGLE) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aeglea Biotherapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Aeglea Biotherapeutics, Inc. since 2005. The reporting company's ticker symbol is AGLE. The reporting company's CIK number is 1636282.
The total value of stock buying since 2005 is $9,498,359.
The total value of stock sales since 2005 is $1,425,518.
The total value of stock option exercises since 2005 is $1,683,303.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aeglea Biotherapeutics, Inc. (AGLE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-10 0 $0 0 $0 18,265 $107,489
2019-06 31,905 $196,459 0 $0 0 $0
2019-05 44,586 $301,334 0 $0 0 $0
2019-02 719 $5,103 0 $0 8,756 $51,529
2018-12 0 $0 0 $0 171,890 $909,813
2018-09 0 $0 6,000 $57,150 0 $0
2018-08 994 $9,075 0 $0 45,833 $253,934
2018-07 0 $0 0 $0 42,173 $277,486
2018-05 0 $0 135,610 $1,368,368 0 $0
2018-02 2,000 $12,040 0 $0 15,211 $83,052
2017-12 45,409 $218,996 0 $0 0 $0
2017-08 1,959 $4,928 0 $0 0 $0
2017-02 111,300 $572,450 0 $0 0 $0
2016-08 2,000 $7,974 0 $0 0 $0
2016-04 817,000 $8,170,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aeglea Biotherapeutics, Inc. insiders (AGLE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-10-04 Quinn Anthony G. (President & CEO) Option Ex 18,265 5.88 107,489
2019-06-14 Quinn Anthony G. (President & CEO) Buy 5,282 6.23 32,912
2019-06-13 Quinn Anthony G. (President & CEO) Buy 14,406 6.17 88,841
2019-06-12 Quinn Anthony G. (President & CEO) Buy 12,217 6.12 74,706
2019-05-22 Quinn Anthony G. (President & CEO) Buy 3,809 6.86 26,129
2019-05-21 Quinn Anthony G. (President & CEO) Buy 13,794 6.89 94,985
2019-05-20 Quinn Anthony G. (President & CEO) Buy 8,989 6.55 58,922
2019-05-17 Quinn Anthony G. (President & CEO) Buy 6,218 6.65 41,337
2019-05-16 Quinn Anthony G. (President & CEO) Buy 5,520 6.83 37,690
2019-05-15 Quinn Anthony G. (President & CEO) Buy 6,256 6.76 42,271
2019-02-15 Quinn Anthony G. (President & CEO) Buy 719 7.10 5,103
2019-02-06 Quinn Anthony G. (President & CEO) Option Ex 8,756 5.88 51,529
2018-12-07 Quinn Anthony G. (President & CEO) Option Ex 171,890 5.29 909,813
2018-09-27 Schuchart Aaron (Chief Business Officer) Sale 6,000 9.53 57,150
2018-08-17 Schuchart Aaron (Chief Business Officer) Option Ex 8,500 3.50 29,750
2018-08-15 Quinn Anthony G. (President & CEO) Buy 994 9.13 9,075
2018-08-13 Georgiou George Option Ex 37,333 6.00 224,184
2018-07-12 Quinn Anthony G. (Interim CEO) Option Ex 38,866 6.67 259,430
2018-07-11 Quinn Anthony G. (Interim CEO) Option Ex 3,307 5.46 18,056
2018-05-11 Novartis Ag Sale 19,550 10.06 196,673
2018-05-10 Novartis Ag Sale 22,725 10.13 230,204
2018-05-09 Novartis Ag Sale 51,230 10.11 517,935
2018-05-08 Novartis Ag Sale 26,557 10.03 266,366
2018-05-07 Novartis Ag Sale 15,548 10.11 157,190
2018-02-15 Quinn Anthony G. (President & CEO) Buy 2,000 6.02 12,040
2018-02-15 Quinn Anthony G. (Interim CEO) Option Ex 15,211 5.46 83,052
2017-12-08 Quinn Anthony G. (Interim CEO) Buy 600 5.07 3,039
2017-12-07 Quinn Anthony G. (Interim CEO) Buy 2,800 4.99 13,966
2017-12-06 Quinn Anthony G. (Interim CEO) Buy 4,888 4.92 24,073
2017-12-05 York Charles N Ii (Chief Financial Officer and VP) Buy 10,241 4.75 48,695
2017-12-05 Quinn Anthony G. Buy 5,065 4.93 24,975
2017-12-04 York Charles N Ii (Chief Financial Officer and VP) Buy 3,259 4.97 16,197
2017-12-04 Quinn Anthony G. Buy 7,956 4.98 39,620
2017-12-01 York Charles N Ii (Chief Financial Officer and VP) Buy 6,500 4.59 29,854
2017-12-01 Quinn Anthony G. Buy 4,100 4.53 18,577
2017-08-15 York Charles N Ii (Chief Financial Officer and VP) Buy 1,959 2.52 4,928
2017-02-21 Isaly Samuel D Buy 7,000 5.36 37,520
2017-02-17 Isaly Samuel D Buy 71,800 5.19 372,642
2017-02-16 Isaly Samuel D Buy 30,500 5.04 153,720
2017-02-15 York Charles N Ii (Chief Financial Officer and VP) Buy 2,000 4.28 8,568
2016-08-15 York Charles N Ii (Chief Financial Officer and VP) Buy 2,000 3.99 7,974
2016-04-12 Quinn Anthony Buy 10,000 10.00 100,000
2016-04-12 Cox Russell J. Buy 7,000 10.00 70,000
2016-04-12 Novartis Ag Buy 300,000 10.00 3,000,000
2016-04-12 Lilly Eli & Co Buy 500,000 10.00 5,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of AGLE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aeglea Biotherapeutics, Inc. (symbol AGLE, CIK number 1636282) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month